NEW YORK (GenomeWeb News) – Fitch Ratings today downgraded its long-term issuer default rating on Thermo Fisher Scientific to 'BBB' from 'BBB+' and assigned a 'BBB' rating to Thermo Fisher's proposed senior notes, which have yet to be priced.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.
A company says it can generate likenesses of people based on their genetic profiles.
IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.
At her blog, Sally Rockey dives into National Institutes of Health funding data.